When a Lab Flags the Sample: Hemolysis, Lipemia, Icterus, and Redraws

A specimen-quality flag means the laboratory detected a condition that may affect one or more measurements in that sample. It is not automatically a diagnosis, and it does not mean every result from the collection is unusable. The report may name hemolysis, lipemia, icterus, or an HIL index. The next task is to learn which test was affected, what the laboratory did with it, and whether another sample is needed.

A blood redraw is one possible response. It is not the universal response, and it should not be arranged by interpreting a color word alone.

Keep the specimen separate from the person

Laboratory instruments test material in a tube, cup, swab, or other container. The condition of that material can change during collection, transport, processing, or storage. Some visible or measured properties can also reflect what was already present in the person's blood.

That creates an important boundary:

• a specimen observation says something about the sample the laboratory received;
• an analytical comment says a particular measurement may be biased, limited, suppressed, or unavailable; and
• a clinical interpretation asks what the valid results mean for the person.

Do not collapse those three layers. “Hemolyzed” on a report does not by itself establish why cells broke apart. “Lipemic” does not prove that a person ignored a fasting instruction. “Icteric” does not, by itself, establish the cause of bilirubin-related color.

What the three terms describe

The CDC guide to collecting and managing human samples describes the terms in specimen-quality language.

Hemolysis means red blood cell membranes have broken and released hemoglobin and other cell contents into serum or plasma. This may happen during the draw or as the sample is handled and transported. NHLBI's hemolytic-anemia overview also describes hemolysis within the body. The flag alone does not distinguish those possibilities.

Lipemia describes cloudy or turbid serum or plasma associated with lipid particles. Recent food intake can contribute in some settings, but a lipemic specimen is not proof of a preparation error. The test protocol, health context, infusions or products documented by the care team, and the laboratory method all matter.

Icterus describes a dark yellow appearance or instrument index associated with bilirubin in the sample. It may interfere with some measurements. It is not a diagnosis attached by the analyzer; the clinical meaning of bilirubin-related findings belongs with the rest of the report and health context. The guide to total, direct, and indirect bilirubin explains why the bilirubin measurements themselves answer a different question from an interference flag.

Many chemistry analyzers estimate these conditions with hemolysis, icterus, and lipemia indices, shortened to HIL indices.

A flag can affect tests differently

Different laboratory methods interact with specimen conditions in different ways. CLSI's C56 standard describes HIL indices as tools laboratories use to assess sample quality and to manage possible interference. Laboratories connect the observed index to the particular assay, instrument, manufacturer information, and their verified procedures.

That is why there is no single consumer-facing HIL number that declares an entire tube good or bad. One ordered measurement might be:

• reported without a comment;
• reported with a caution;
• withheld or canceled because the laboratory cannot support the result;
• repeated on the same sample by a permitted process;
• performed with another method; or
• requested from a new specimen.

The site's guides to electrolytes and ALT versus AST explain relationships among measured substances. A specimen-quality note adds an earlier question: did the laboratory consider each displayed measurement fit to report? Only after that question is resolved does interpretation of the pattern make sense.

Read the status line before reading the number

Start with the exact words shown beside the test. Common report designs vary, so identify:

1. the affected test name;
2. whether a numeric result is displayed;
3. whether the result status says final, preliminary, canceled, not performed, or another laboratory-specific term;
4. the full specimen comment, including any named index;
5. the collection date, clock time, and specimen type; and
6. any instruction about recollection or contacting the laboratory.

Do not detach the number from the flag when copying results into a spreadsheet or portal message. A better entry is:

Preserve the original report. Transcription can omit a symbol, qualifier, or method note.

Work through a mixed report

Imagine a fictional report containing five ordered measurements. Three have final values and no specimen comment. One has a number plus “possible interference from hemolysis.” One says “not reported—recollection requested.”

It would be inaccurate to say “the whole panel was rejected.” It would also be inaccurate to copy all four numbers into a trend without the warning. The practical approach is to keep the valid status of each item visible and ask about the two affected tests separately:

• Is the displayed, flagged value intended for clinical interpretation?
• Was the unreported test canceled because of this specimen?
• Does one new blood draw cover both issues?
• Does the laboratory need a new order?

Now change the scenario: the report carries a lipemia index, but every ordered result is final and there is no recollection request. The word lipemia alone does not authorize fasting and arranging another draw. Ask whether any specific result was affected and whether the ordering team needs follow-up.

These examples avoid predicting the direction of error. A method can respond to interference in a way that is specific to the measurement. A home rule such as “hemolysis always raises results” is unsafe and incomplete.

Questions that make a redraw request usable

When the laboratory or ordering office requests another blood sample, get enough information to complete it correctly:

• Scope: Which exact tests need another specimen? Will already reported tests remain final?
• Reason: Is this a specimen-quality recollection, a confirmation requested for clinical interpretation, or both?
• Order: Is the existing order still active, or must the ordering office submit another one?
• Timing: Is the redraw routine, time-sensitive, or tied to a specific collection window?
• Preparation: Are there written instructions for food, drink, activity, posture, or medicines? Do not invent fasting because lipemia was mentioned.
• Record: How will the new result be linked to the canceled or flagged one?

If the request is urgent, use the contact route provided by the care team or laboratory. Do not wait for an online explanation of the interference term.

The answers should come from the organization responsible for the order and testing. A general guide cannot know the assay, specimen requirement, or urgency.

Prepare for recollection without assigning blame

The WHO phlebotomy guideline emphasizes that collection and transport steps affect quality and recommends standardized processes for safe blood collection. Patients do not control all of those steps.

Before recollection:

• bring the new or existing order as instructed;
• bring the exact preparation instructions;
• report what happened during the earlier draw if it may help, such as a difficult collection, a line draw, a long transport delay, or an instruction that could not be followed;
• disclose relevant medicines and supplements without stopping them independently;
• follow only the hydration, food, activity, posture, and timing directions actually provided; and
• ask staff to record any important departure from the protocol.

A difficult draw is not a personal failure. It is information collection staff can use to choose a safe approach. Likewise, a repeated flag does not prove poor technique; it may require the laboratory and care team to consider specimen handling, the method, and biological context.

Do not try to prevent hemolysis by directing the phlebotomist's equipment or technique. Collection professionals must follow their procedures and assess the situation in person.

Understand what a successful redraw can establish

A new specimen may allow a test to be measured without the earlier interference. It does not retroactively prove the first flag was caused during collection, and it does not guarantee that a biological contributor will disappear.

Compare the two reports at the status level first:

Avoid averaging a flagged and unflagged value. Avoid calling the unflagged number “the true result” unless the responsible laboratory or clinician explains how it should be used. The guide to why reference intervals vary explains why a clean-looking number still requires its own report details.

Close the loop

A specimen problem is resolved administratively only when the record answers:

• which tests were affected;
• whether any results remain usable;
• whether recollection was ordered and completed;
• how the replacement result links to the original report; and
• who will interpret the final set.

Keep the original flag visible and the replacement report separate. If a portal still shows an item as overdue after recollection, ask the ordering office to reconcile the order.

Connect flags to tests; document next steps.